A Systematic Review and Network Meta‐Analysis of Regorafenib and TAS‐102 in Refractory Metastatic Colorectal Cancer
Oncologist - United States
doi 10.1634/theoncologist.2019-0189
Full Text
Open PDFAbstract
Available in full text
Date
June 6, 2019
Authors
Publisher
Alphamed Press